医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

纳米羟基磷灰石/聚酰胺66/成骨细胞/血管内皮生长因子165组织工程骨修复骨缺损再血管化与成骨活性

Revascularization and osteogenesis during repair of bone defects with tissue-engineered bone of nano-hydroaoatite crystal/polyamide 66/rabbit osteoplast/vascular endothelial growth factor

摘要目的 探讨以转染血管内皮生长因子165(vascular endothelial growth factor,VEGF165)基因的成骨细胞为种子细胞复合纳米网孔羟基磷灰石/聚酰胺66(nano-hydrxyapatite crystal/polyamide 66,n-HA/PA66)支架,构建的n-HA/PA66/成骨细胞/VEGF165组织工程骨修复兔桡骨缺损早期快速再血管化和成骨的能力。 方法 选新西兰大白兔56只,采用随机数字表法分成A、B两组,制作双侧桡骨骨缺损模型。A1组:将n-HA/PA66复合材料植入A组左侧骨缺损;A2组:将n-HA/PA66/ VEGF165复合材料植入A组右侧骨缺损;B1组:将n-HA/PA66/成骨细胞/VEGF165复合材料植入B组左侧骨缺损;B2组:将n-HA/PA66/成骨细胞复合材料植入B组右侧骨缺损。术后2,4,8,12周进行大体观察,数字X线摄片(DR)、组织学切片、血管计数、扫描电镜观察。 结果 B1组各个时相点各种观察指标均表明其成骨活性及再血管化明显优于其他各组,差异有统计学意义(P<0.05)。A1、A2组成骨活性及再血管化远不如B1、B2组,A1、A2两组之间差异无统计学意义。 结论 n-HA/PA66/成骨细胞/VEGF1 65组织工程骨具有良好的诱导成骨作用,在早期骨愈合中能促进新生血管快速形成,加快骨缺损的愈合。

更多

abstractsObjective To employ the vascular endothelial growth factor (VEGF165) gene transfected rabbbit osteoplast to combine with the porous nano-hydrxyapatite crystal (n-HA)/polyam ide 66(/PA66) so as to evaluate the osteogenesis and rapid revascularization early after repair of the rabbit radius bone defects with the tissue-engineered bone (n-HA/PA66/osteoplast/VEGF165). Methods The animal models of bilateral radius bone defects were created in 56 New Zealand white rabbits that were then randomly divided into Group A and Group B.In Group A, the animals were implanted with n-HA/PA66on the left bone defects (Group Al) and with n-HA/PA66/VEGF165 composite materials on the right bone defects (Group A2). In Group B, the animals were implanted with n-HA/PA66/osteoplast/VEGF165 composite materials on the left side (Group B1) and with n-HA/PA66/osteoplast on the right side (Group B2).Gross, digital radiography, histological sections, vessel count and scanning electron microscopy (SEM) were performed at 2, 4, 8 and 12 weeks after operation. Results The osteogenesis and revascularization in Group B1 was superior to that in the other groups at each time point, with statistical difference (P <0.05).The revascularization and osteogenesis in Groups B1 and B2 was far better than that in Groups A1 and A2, with no statistical difference between Group A1 and Group A2. Conclusions The new tissue-engineered bone (n-HA/PA66/osteoplast/VEGF165) has a perfect osteogenetic effect and can promote rapid revascularization and the bone healing in the early stage after repair of the bone defects.

More
广告
  • 浏览394
  • 下载56
中华创伤杂志

中华创伤杂志

2011年27卷9期

852-857页

ISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷